Combined Immunosuppression for Pediatric Crohn's Disease

Clinical trial NCT05043870 · RECRUITING

Trial details

NCT number: NCT05043870
Sponsor: Children's Hospital of Fudan University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease Infliximab Immunosuppression Children, Only

Start date: 2022-10-10
Primary completion: 2026-10-31
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.